NutriLeads BV signed a commercial agreement with Royal DSM to bring pre-mix and market-ready solutions that feature BeniCaros the U.S. supplement market.
NutriLeads BV (Wageningen, the Netherlands) signed a commercial agreement with Royal DSM to bring pre-mix and market-ready solutions that feature BeniCaros the U.S. supplement market. BeniCaros is NutriLeads’ bioactive polysaccharide ingredient derived from upcycled carrot pomace for immune health.
“We are pleased to partner with DSM to accelerate the availability of BeniCaros to U.S. consumers through innovative new premix and market-ready solutions,” said Joana Carneiro, PhD, NutriLeads’CEO, in a press release. “DSM’s deep expertise in every stage of product development will help BeniCaros more quickly achieve its tremendous potential.”
“Consumers increasingly recognize the link between immune health and gut health, as well as the importance of well-balanced microbiota to their overall health,” said Martin Dos Ramos, vice president, Human Nutrition & Care, Dietary Supplements, at DSM. “BeniCaros is an attractive, science-based immune health ingredient that supports these top consumer health concerns. We see excellent potential for product innovation. This agreement further strengthens our end-to-end offerings across the entire product development cycle and supports our partnership with customers to shape and drive new markets.”
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.